AB

Abu Bokkar Siddik

Director Director DIN 08255571
DIN 08255571 First appointment Oct 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value Locked Premium profile

About Abu Bokkar Siddik

Data last updated:

Abu Bokkar Siddik has 7 years in corporate governance. Formerly with 1 company, such as Fams Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08255571
Primary Designation Director
First Appointment 12 Oct 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Fams Pharma Private Limited U74999AS2018PTC018800
Director12 Oct 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fams Pharma Private Limited
Premium access

Shareholding and investment profile for Abu Bokkar Siddik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abu Bokkar Siddik

Abu Bokkar Siddik has 7 years in corporate governance. Formerly with 1 company, such as Fams Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Abu Bokkar Siddik is associated with 0 companies as a director.

Abu Bokkar Siddik has expertise in General Business.

Abu Bokkar Siddik has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available